
Frances Chin Han
Examiner (ID: 5174)
| Most Active Art Unit | 3206 |
| Art Unit(s) | 3722, 3641, 3206, 3204 |
| Total Applications | 974 |
| Issued Applications | 799 |
| Pending Applications | 31 |
| Abandoned Applications | 143 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9641999
[patent_doc_number] => 20140220110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPOSOMES'
[patent_app_type] => utility
[patent_app_number] => 14/171619
[patent_app_country] => US
[patent_app_date] => 2014-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 18601
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14171619
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/171619 | REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPOSOMES | Feb 2, 2014 | Abandoned |
Array
(
[id] => 9642000
[patent_doc_number] => 20140220111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPOSOMES'
[patent_app_type] => utility
[patent_app_number] => 14/171654
[patent_app_country] => US
[patent_app_date] => 2014-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 18777
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14171654
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/171654 | REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPOSOMES | Feb 2, 2014 | Abandoned |
Array
(
[id] => 9642001
[patent_doc_number] => 20140220112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'TRANSFORMATION OF DRUG CYCLODEXTRIN COMPLEX COMPOSITIONS INTO COMPOSITIONS OF MIXTURES OF LIPID VESICLE ENCAPSULATED DRUG AND CYCLODEXTRIN DRUG COMPLEXES'
[patent_app_type] => utility
[patent_app_number] => 14/171728
[patent_app_country] => US
[patent_app_date] => 2014-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15309
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14171728
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/171728 | TRANSFORMATION OF DRUG CYCLODEXTRIN COMPLEX COMPOSITIONS INTO COMPOSITIONS OF MIXTURES OF LIPID VESICLE ENCAPSULATED DRUG AND CYCLODEXTRIN DRUG COMPLEXES | Feb 2, 2014 | Abandoned |
Array
(
[id] => 9490665
[patent_doc_number] => 20140141071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'ORALLY ADMINISTRABLE LIPOSOMALLY ENCAPSULATED REDUCED GLUTATHIONE, WITH N-O ENHANCING COMPOUNDS FOR REVERSAL AND PREVENTION OF OXIDATION OF CHOLESTEROL AND OF LOW DENSITY LIPOPROTEIN'
[patent_app_type] => utility
[patent_app_number] => 14/164382
[patent_app_country] => US
[patent_app_date] => 2014-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16850
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14164382
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/164382 | ORALLY ADMINISTRABLE LIPOSOMALLY ENCAPSULATED REDUCED GLUTATHIONE, WITH N-O ENHANCING COMPOUNDS FOR REVERSAL AND PREVENTION OF OXIDATION OF CHOLESTEROL AND OF LOW DENSITY LIPOPROTEIN | Jan 26, 2014 | Abandoned |
Array
(
[id] => 9462710
[patent_doc_number] => 20140127136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'LIPOSOMES USEFUL FOR DRUG DELIVERY TO THE BRAIN'
[patent_app_type] => utility
[patent_app_number] => 14/151632
[patent_app_country] => US
[patent_app_date] => 2014-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 54841
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14151632
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/151632 | LIPOSOMES USEFUL FOR DRUG DELIVERY TO THE BRAIN | Jan 8, 2014 | Abandoned |
Array
(
[id] => 10305358
[patent_doc_number] => 20150190359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-09
[patent_title] => 'STABLE LIPOSOMAL FORMULATIONS FOR OCULAR DRUG DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 14/149159
[patent_app_country] => US
[patent_app_date] => 2014-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2339
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14149159
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/149159 | Stable liposomal formulations for ocular drug delivery | Jan 6, 2014 | Issued |
Array
(
[id] => 9641998
[patent_doc_number] => 20140220109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'NOVEL COCHLEATE FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/145268
[patent_app_country] => US
[patent_app_date] => 2013-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10992
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14145268
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/145268 | NOVEL COCHLEATE FORMULATIONS | Dec 30, 2013 | Abandoned |
Array
(
[id] => 11113428
[patent_doc_number] => 20160310400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'METHOD FOR PREPARING LIPOSOMES OF RETINALDEHYDE OR OTHER PRECURSORS OF RETINOIC ACID AND PRODUCT THUS OBTAINED'
[patent_app_type] => utility
[patent_app_number] => 15/105327
[patent_app_country] => US
[patent_app_date] => 2013-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 767
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15105327
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/105327 | METHOD FOR PREPARING LIPOSOMES OF RETINALDEHYDE OR OTHER PRECURSORS OF RETINOIC ACID AND PRODUCT THUS OBTAINED | Dec 22, 2013 | Abandoned |
Array
(
[id] => 9421316
[patent_doc_number] => 20140105967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-17
[patent_title] => 'STABILIZED COMPOSITION AND METHOD FOR DERMATOLOGICAL TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 14/107515
[patent_app_country] => US
[patent_app_date] => 2013-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4480
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14107515
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/107515 | STABILIZED COMPOSITION AND METHOD FOR DERMATOLOGICAL TREATMENT | Dec 15, 2013 | Abandoned |
Array
(
[id] => 9517813
[patent_doc_number] => 20140154305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'USE OF UMIROLIMUS AND ITS DERIVATIVES FOR TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/093876
[patent_app_country] => US
[patent_app_date] => 2013-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5188
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14093876
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/093876 | Use of umirolimus and its derivatives for treating cancer | Dec 1, 2013 | Issued |
Array
(
[id] => 9383502
[patent_doc_number] => 20140086983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'METHODS FOR THE PREPARATION OF LIPOSOMES COMPRISING DRUGS'
[patent_app_type] => utility
[patent_app_number] => 14/088657
[patent_app_country] => US
[patent_app_date] => 2013-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9764
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14088657
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/088657 | Methods for the preparation of liposomes comprising drugs | Nov 24, 2013 | Issued |
Array
(
[id] => 9490660
[patent_doc_number] => 20140141066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'Encapsulated Ascorbic Acid Composition'
[patent_app_type] => utility
[patent_app_number] => 14/084102
[patent_app_country] => US
[patent_app_date] => 2013-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3449
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14084102
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/084102 | Encapsulated Ascorbic Acid Composition | Nov 18, 2013 | Abandoned |
Array
(
[id] => 9369876
[patent_doc_number] => 20140079749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-20
[patent_title] => 'COMPOSITIONS AND METHODS FOR IMPROVED SKIN CARE'
[patent_app_type] => utility
[patent_app_number] => 14/080883
[patent_app_country] => US
[patent_app_date] => 2013-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17863
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14080883
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/080883 | COMPOSITIONS AND METHODS FOR IMPROVED SKIN CARE | Nov 14, 2013 | Abandoned |
Array
(
[id] => 9560761
[patent_doc_number] => 20140178462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'AMPHOTERIC LIPOSOMES COMPRISING NEUTRAL LIPIDS'
[patent_app_type] => utility
[patent_app_number] => 14/049669
[patent_app_country] => US
[patent_app_date] => 2013-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 72567
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14049669
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/049669 | AMPHOTERIC LIPOSOMES COMPRISING NEUTRAL LIPIDS | Oct 8, 2013 | Abandoned |
Array
(
[id] => 10317150
[patent_doc_number] => 20150202153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-23
[patent_title] => 'LIPOSOMAL DRUG DELIVERY SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 14/433285
[patent_app_country] => US
[patent_app_date] => 2013-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 22636
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14433285
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/433285 | LIPOSOMAL DRUG DELIVERY SYSTEM | Oct 3, 2013 | Abandoned |
Array
(
[id] => 9362744
[patent_doc_number] => 20140072617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-13
[patent_title] => 'METHOD FOR PREVENTING OR SLOWING DOWN THE APPEARANCE OF THE EFFECTS OF SKIN AGEING USING A TOCOPHERYL PHOSPHATE IN LIPOSOMES'
[patent_app_type] => utility
[patent_app_number] => 14/046481
[patent_app_country] => US
[patent_app_date] => 2013-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6643
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14046481
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/046481 | METHOD FOR PREVENTING OR SLOWING DOWN THE APPEARANCE OF THE EFFECTS OF SKIN AGEING USING A TOCOPHERYL PHOSPHATE IN LIPOSOMES | Oct 3, 2013 | Abandoned |
Array
(
[id] => 9448988
[patent_doc_number] => 20140120157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'TARGETED LIPOSOMES'
[patent_app_type] => utility
[patent_app_number] => 14/030563
[patent_app_country] => US
[patent_app_date] => 2013-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 29712
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 31
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14030563
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/030563 | TARGETED LIPOSOMES | Sep 17, 2013 | Abandoned |
Array
(
[id] => 9369900
[patent_doc_number] => 20140079773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-20
[patent_title] => 'ENCAPSULATING LIPOSOMES'
[patent_app_type] => utility
[patent_app_number] => 14/030131
[patent_app_country] => US
[patent_app_date] => 2013-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11638
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14030131
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/030131 | ENCAPSULATING LIPOSOMES | Sep 17, 2013 | Abandoned |
Array
(
[id] => 9338423
[patent_doc_number] => 20140065205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'PREVENTING PULMONARY RECURRENCE OF CANCER WITH LIPID-COMPLEXED CISPLATIN'
[patent_app_type] => utility
[patent_app_number] => 14/018012
[patent_app_country] => US
[patent_app_date] => 2013-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28209
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14018012
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/018012 | Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin | Sep 3, 2013 | Issued |
Array
(
[id] => 13659009
[patent_doc_number] => 10159646
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-25
[patent_title] => Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
[patent_app_type] => utility
[patent_app_number] => 13/965158
[patent_app_country] => US
[patent_app_date] => 2013-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 7452
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13965158
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/965158 | Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery | Aug 11, 2013 | Issued |